Robin Dubin, Founder and Executive Director at AliveAndKickn, shared a post on LinkedIn:
“I’ll be at ASCO this week representing the Lynch syndrome community and I’m looking to connect with people who are moving the needle on hereditary cancer.
Through AliveandKick’n, I work with engaged Lynch community participants who are actively participating in research, surveillance, and education. Through ACED, I help shape how patient and public involvement informs international early detection science. And as a patient advocate on the NCI CAP-IT Steering Committee, I’m working to ensure the hereditary cancer community informs cancer prevention trial design.
If you’re in Lynch syndrome, MMR-deficient cancers, or inherited cancer risk and you’re thinking about partnership, community access, or patient-centered research design find me.”
Other articles featuring Robin Dubin on OncoDaily.